Tramadol
ConZip
Opioid Analgesic
NADAC/unit
$0.0239
No Shortage
Tier 1: 75.1%
PA Req: 56.8%
12 Manufacturers
20 ANDAs
Tramadol hydrochloride extended-release tablets are indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternati....
vs. brand ConZip: Generic saves up to 100% per unit
Market Intelligence
2024-05-15 Class II Recall: Rubicon Research Private Limited
Generic Manufacturers
AMNEAL PHARMACEUTICALS OF NEW YORK LLCAUROBINDO PHARMA LTDCIPHER PHARMACEUTICALS INCCSPC OUYI PHARMACEUTICAL CO LTDGRAVITI PHARMACEUTICALS PRIVATE LTDLUPIN LTDMACLEODS PHARMACEUTICALS LTDRUBICON RESEARCH LTDSENORES PHARMACEUTICALS INCSTRIDES PHARMA GLOBAL PTE LTDSUN PHARMACEUTICAL INDUSTRIES INCTEVA PHARMACEUTICALS USA INCUNICHEM LABORATORIES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.